Semaglutide, found in Novo Nordisk's Ozempic, may reduce Alzheimer's risk in type 2 diabetes patients, per new research. FDA considers banning compounded versions.

Add Alzheimer's disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new ...

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...

The UK's drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as ...